98 related articles for article (PubMed ID: 8875442)
1. Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on adenohypophyseal Hormone secretion in normal men.
Chiodera P; Volpi R; Capretti L; Caffarri G; Magotti MG; Coiro V
Neuroendocrinology; 1996 Sep; 64(3):242-6. PubMed ID: 8875442
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on arginine vasopressin and oxytocin secretion in man.
Chiodera P; Volpi R; Capretti L; Coiro V
Neuroreport; 1995 Jul; 6(11):1490-2. PubMed ID: 7579131
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion.
Huang SK; Pan JT
Neuroendocrinology; 1996 Sep; 64(3):208-14. PubMed ID: 8875438
[TBL] [Abstract][Full Text] [Related]
4. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on hormone secretion from sheep pituitary cells in vitro.
Sawangjaroen K; Anderson ST; Curlewis JD
J Neuroendocrinol; 1997 Apr; 9(4):279-86. PubMed ID: 9147291
[TBL] [Abstract][Full Text] [Related]
5. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on prolactin, luteinizing hormone and growth hormone secretion in the ewe.
Sawangjaroen K; Curlewis JD
J Neuroendocrinol; 1994 Oct; 6(5):549-55. PubMed ID: 7827625
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
[TBL] [Abstract][Full Text] [Related]
7. Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas.
Robberecht P; Vertongen P; Velkeniers B; de Neef P; Vergani P; Raftopoulos C; Brotchi J; Hooghe-Peters EL; Christophe J
J Clin Endocrinol Metab; 1993 Nov; 77(5):1235-9. PubMed ID: 8077316
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenylate cyclase-activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of luteinizing hormone-releasing hormone.
Culler MD; Paschall CS
Endocrinology; 1991 Oct; 129(4):2260-2. PubMed ID: 1915106
[TBL] [Abstract][Full Text] [Related]
9. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
10. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
[TBL] [Abstract][Full Text] [Related]
13. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase-activating polypeptide releases 7B2, adrenocorticotrophin, growth hormone and prolactin from the mouse and rat clonal pituitary cell lines AtT-20 and GH3.
Propato-Mussafiri R; Kanse SM; Ghatei MA; Bloom SR
J Endocrinol; 1992 Jan; 132(1):107-13. PubMed ID: 1310712
[TBL] [Abstract][Full Text] [Related]
16. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
[TBL] [Abstract][Full Text] [Related]
17. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
18. PACAPs stimulate duodenal bicarbonate secretion at PACAP receptors in the rat.
Takeuchi K; Takehara K; Kato S; Yagi K
Am J Physiol; 1997 Mar; 272(3 Pt 1):G646-53. PubMed ID: 9124587
[TBL] [Abstract][Full Text] [Related]
19. An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neuro-transmitters in exocrine pancreas of rats.
Wheeler S; Eardley JE; McNulty KF; Sutcliffe CP; Morrison JD
Exp Physiol; 1997 Jul; 82(4):729-47. PubMed ID: 9257115
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
